Household & Personal Products

PG’s $3.8 billion buy of science‑based wellness firm Thorne unlocks $240 m annual earnings, deep data insights, and global reach, but hinges on regulatory and integration success.

Colgate‑Palmolive’s August 4, 2026 Rule 144 filings reveal two senior officer cash‑less share sales, offering insight into executive liquidity and compliance practices.

PG’s 2026 10‑K reveals a strategic pivot: steady revenue growth, 40% GHG cut target, and a $3.8 bn acquisition of Thorne to boost science‑driven wellness and ESG appeal.

Clorox’s Q4 2026 earnings dip shows how GOJO’s acquisition and ERP rollout reshape margins, yet offer a growing hygiene edge and digital‑first efficiency gains.

Beiersdorf’s 2026 outlook shows a sharp shift from growth to a negative trajectory, driven by demand slowdown, macro drag, and new clean‑beauty competition—how the turnaround plan could reshape margins and shareholder value.

Unilever PLC’s 6‑K filing reveals 2B voting shares, treasury stock, and a senior executive’s €78k share sale—transparent governance updates, no performance data.

PG’s Q2 2026 earnings beat estimates, with EPS $1.43 and a 2027 guide of $6.89‑$7.11, while a new chairman and $1.0885 dividend signal steady, income‑focused growth.

Unilever’s 2026 H1 results show modest revenue growth driven by volume and a high‑margin pivot, boosting margins while navigating cost pressures and China’s premium‑product surge.

Explore L’Oréal’s latest quarterly earnings—8% revenue growth, dermatology surges, EU sustainability impacts, and e‑commerce strategies that shape future gains.

Procter & Gamble’s latest Q4 results show a five‑year sales high but flat volumes and shrinking EBITDA, spotlighting margin risks, leadership change, and the need for sustainable, digital‑commerce strategies.